Abstract
Factor XIIIa (FXIIIa), the blood coagulation enzyme, functions as a transglutaminase to covalently stabilize fibrin clots by introducing γ-glutamyl-ε-lysyl peptide bonds between fibrin molecules (for detailed reviews, see references 1 and 2). The FXIII proenzyme exists in two zymogenic forms.3 Extracellular or plasma FXIII is composed of two subunits, A(Mr =80,500)4 and B(M =76,500),5 associated non-covalently as a tetrameric complex, A2B2.6,7 Intracellular FXIII is a dimer of only A subunits, A2.6 The A chains in both zymogens are identical and contain the active center sulfhydryl group.7,8 Upon activation by thrombin in the presence of calciurn ions, both zymogens give rise to the same enzymatic activity, FXIIIa.8,9
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lorand L, Losowsky MS, Miloszewski KJM: Human factor XIII: Fibrin-stabilizing factor. Prog Hemost Thromb 5:245, 1980
McDonagh J: Structure and function of factor XIII, in Coleman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis, Basic Principles and Clinical Practice. Philadelphia, Lippincott, 1982, p 164
Dvilansky A, Britten AFH, Loewy AG: Factor XIII assay by an isotope method. I. Factor XIII (transamidase) in plasma, serum, leukocytes, erythrocytes and platelets and evaluation of screening tests of clot solubility. Br J Haematol 18:399, 1970
Ichinose A, Hendrickson LE, Fujikawa K, Davie EW: Amino acid sequence of the a subunit of human factor XIII. Biochemistry 25:6900, 1986
Ichinose A, McMullen BA, Fujikawa K, Davie EW: Amino acid sequence of the b subunit of human factor XIII, a protein composed of ten repetitive segments. Biochemistry 25:4633, 1986
Schwartz ML, Pizzo SV, Hill RL, McKee PA: Human factor XIII from plasma and platelets: Molecular weights, subunit structure, proteolytic activation and crosslinking of fibrinogen and fibrin. J Biol Chem 248:1395, 1973
Chung SI, Lewis MS, Folk JE: Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structure. J Biol Chem 249:940, 1974
Curtis CG, Brown KL, Credo RB, Domanik RA, Gray A, Stenberg P, Lorand L: Calcium dependent unmasking of active center cysteine during activation of fibrin stabilizing factor. Biochemistry 13:3774, 1974
Freyssinet JM, Lewis BA, Holbrook JJ, Shore JD: Protein-protein interactions in blood clotting. The use of polarization of fluorescence to measure the dissociation of plasma factor XIIIa. Biochem J 169:403, 1978
Nagy JA, Henriksson P, McDonagh J: Biosynthesis of factor XIII B subunit by human hepatoma cell lines. Blood 68:1272, 1986
Kradin RL, Lynch GW, Kurnick JT, Erikson M, Colvin RB, McDonagh J: Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages. Blood 69:778, 1987
Kiesselback TH, Wagner RH: Demonstration of factor XIII in human megakaryocytes by a fluorescent antibody technique. Ann NY Acad Sci 202:318, 1972
Chung SI: Multiple molecular forms of transglutaminases in human and guinea pig, in Markert CL (ed): Isozymes, vol 1. Orlando, FL, Academic, 1975, p 259
Bohn H, Haupt H, Kranz T: Die molekulare Struktur der fibrinstabilisierenden Faktoren des Menschen. Blut 25:235, 1972
Colvin R, Lynch G, McDonagh J, Erikson M, Karnick J, Power K, Kradin R: Factor XIII A subunit is synthesized and expressed by macrophages. Fed Proc 44:906, 1985
Muszbek L, Adany R, Szeyedi G, Polgar J, Kavai M: Factor XIII of blood coagulation in human monocytes. Thromb Res 37:401, 1985
Henriksson P, Becker S, Lynch G, McDonagh J: Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 76:528, 1985
Weisberg LJ, Shiu DT, Greenberg CS, Kan YW, Shuman MA: Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. J Clin Invest 79:649, 1987
Leu RW, Herriot MJ, Moore PE, Orr GR, Birkbichler P: Enhanced transglutaminase activity associated with macrophage activation. Exp Cell Res 141:191, 1982
Murtaugh MP, Mehta K, Johnson J, Myers M, Juliano RL, Davies PJA: Induction of tissue transglutaminase in mouse peritoneal macrophages. J Biol Chem 258:11074, 1983
Murtaugh M, Arend WP, Davies PJ: Induction of tissue transglutaminase in human peripheral blood monocytes. J Exp Med 159:114, 1984
Mehta K, Lopez-Berestein G, Moore WT, Davies PJ: Interferon-γ requires serum retinoids to promote the expression of tissue transglutaminase in cultured human blood monocytes. J Immunol 134:2053, 1985
Workman EF Jr, Lundblad RL: The role of the liver in the biosynthesis of the non-vitamin K-dependent clotting factors. Semin Thromb Hemost 4:15, 1977
Lee SY, Chung SI: Biosynthesis and degradation of plasma protransglutaminase (factor XIII). Fed Proc 35:1486, 1976
Ikematsu S: An approach to the metabolism of factor XIII. Acta Haematol Jpn 44:1499, 1981
Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB: Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615, 1979
Knowles BB, Howe CC, Aden DP: Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209:497, 1980
Fair DS, Plow EF: Synthesis and secretion of the fibrinolytic components, including α2-antiplasmin, by a human hepatoma cell line. J Lab Clin Med 101:372, 1983
Levin EG, Fair DS, Loskutoff DJ: Human hepatoma cell line plasminogen activator. J Lab Clin Med 102:500, 1983
Yu S, Sher B, Kudryk B, Redman CM: Intracellular assembly of human fibrinogen. J Biol Chem 258:13407, 1983
Yu S, Sher B, Kudryk B, Redman CM: Fibrinogen precursors. Order of assembly of fibrinogen chains. J Biol Chem 259:10574, 1984
Wilson DB, Salem HH, Mruk JS, Maruyama I, Majerus PW: Biosynthesis of coagulation factor V by a human hepatocellular carcinoma cell line. J Clin Invest 73:654, 1984
Fair DS, Bahnak BR: Human hepatoma cells secrete single chain factor X, prothrombin and antithrombin III. Blood 64:194, 1984
Morris KM, Aden DP, Knowles BB, Colten HR: Complement biosynthesis by the human hepatoma-derived cell line Hep G2. J Clin Invest 70:906, 1982
Goldberger G, Arnaout MA, Aden D, Kay R, Rits M, Colten HR: Biosynthesis and postsynthetic processing of human C3b/C4b inactivator (factor I) in three hepatoma cell lines. J Biol Chem 259:6492, 1984
Alexander JJ, Bey EM, Geddes EW, Lecatsas G: Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50:2124, 1974
Lorand L, Campbell-Wilkes LK, Cooperstein L: A filter paper assay for transamidating enzymes using radioactive amine substrates. Anal Biochem 50:623, 1972
Godal HC, Gravem K, Brossted F, Nyvold N: Quantitation of factor XIII by SDS Polyacrylamide gel electrophoresis. Thromb Res 35:577, 1984
Henriksson P, McDonagh J: Factor XIII activation and interactions, in Egbring R, Klingemann HG (eds): Factor XIII and Fibronectin. Marburg, Germany, Med Verlagsgesellschaft, 1983, p 1
Simon D, Knowles BB: Hepatocellular carcinoma cell line and peripheral blood lymphocytes from the same patient contain common chromosomal alterations. Lab Invest 55:657, 1986
Grundmann U, Amann E, Zettlmeissl G, Kupper HA: Characterization of cDNA coding for human factor XIIIa. Proc Natl Acad Sci 83:8024, 1986
Skrzynia C., Reisner HM, McDonagh J: Characterization of the catalytic subunit of factor XIII by radioimmunoassay. Blood 60:1089, 1982
Gates GA, Henley KS, Pollard HM, Schmidt E, Schmidt FW: The cell populations of human liver. J Lab Clin Med 57:182, 1961
Grinnell F: Fibronectin and wound healing. J Cell Biochem 26:107, 1984
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nagy, J.A., Kradin, R.L., McDonagh, J. (1988). Biosynthesis of Factor XIII A and B Subunits. In: Zappia, V., Galletti, P., Porta, R., Wold, F. (eds) Advances in Post-Translational Modifications of Proteins and Aging. Advances in Experimental Medicine and Biology, vol 231. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-9042-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4684-9042-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-9044-2
Online ISBN: 978-1-4684-9042-8
eBook Packages: Springer Book Archive